Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) has released its 2026 third quarter report.
For the first three quarters, the company recorded operating revenue of 1.623 billion yuan, representing a year-on-year increase of 8.29%.
The company reported a net loss attributable to shareholders of 231 million yuan, while the net loss after deducting non-recurring gains and losses stood at 286 million yuan. Basic earnings per share came in at -0.18 yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.